Neuren Pharmaceuticals | NEU - Beneficio Bruto En Ventas

Precio De Mercado
11.30
Cambio Diario
-0.19 -1.65%
Mensual
-11.09%
Anual
-10.46%
Q1 Expectativa
11.22




Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Dianthus Therapeutics USD 284K 112K 2025-12
Genetic Signatures AUD 4.75M 190K 2024-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
Medical Developments International AUD 7.35M 7.37M 2025-06
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organon & Co USD 854M 3M 2025-12
Paradigm Biopharmaceuticals AUD -9K 423.94K 2025-06
PYC Therapeutics AUD 5.83M 750K 2025-06
Starpharma Holdings AUD -736K 2.82M 2025-06
Tectonic Therapeutic USD 0 0 2025-03
Telix Pharmaceuticals AUD 217.82M 9.23M 2025-12
Viatris USD 1.15B 223.6M 2025-12
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12